Search | VHL Search Portal

1.

Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer.

Philips, Ramez; Alnemri, Angela; Amin, Dev; Patel, Jena; Topf, Michael C; Johnson, Jennifer M; BarAd, Voichita; Axelrod, Rita; Argiris, Athanassios; Fundakowski, Christopher; Luginbuhl, Adam J; Cognetti, David M; Curry, Joseph M.

Cancer ; 130(6): 863-875, 2024 03 15.

Article in English | MEDLINE | ID: mdl-37788128

2.

Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives.

Bauman, Julie E; Duvvuri, Umamaheswar; Thomas, Sufi; Gooding, William E; Clump, David A; Karlovits, Brian; Wehbe, Ahmad; Miller, Frank R; Kim, Seungwon; Sen, Malabika; Heron, Dwight E; Grandis, Jennifer R; Argiris, Athanassios.

Cancer ; 124(19): 3881-3889, 2018 10 01.

Article in English | MEDLINE | ID: mdl-30291796

3.

Induced Bias Due to Crossover Within Randomized Controlled Trials in Surgical Oncology: A Meta-regression Analysis of Minimally Invasive versus Open Surgery for the Treatment of Gastrointestinal Cancer.

Garas, George; Markar, Sheraz R; Malietzis, George; Ashrafian, Hutan; Hanna, George B; Zacharakis, Emmanouil; Jiao, Long R; Argiris, Athanassios; Darzi, Ara; Athanasiou, Thanos.

Ann Surg Oncol ; 25(1): 221-230, 2018 Jan.

Article in English | MEDLINE | ID: mdl-29110271

4.

Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.

Tarhini, Ahmad A; Rafique, Imran; Floros, Theofanis; Tran, Phu; Gooding, William E; Villaruz, Liza C; Burns, Timothy F; Friedland, David M; Petro, Daniel P; Farooqui, Mariya; Gomez-Garcia, Jose; Gaither-Davis, Autumn; Dacic, Sanja; Argiris, Athanassios; Socinski, Mark A; Stabile, Laura P; Siegfried, Jill M.

Cancer ; 123(15): 2936-2944, 2017 Aug 01.

Article in English | MEDLINE | ID: mdl-28472537

5.

A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Jimeno, Antonio; Posner, Marshall R; Wirth, Lori J; Saba, Nabil F; Cohen, Roger B; Popa, Elizabeta C; Argiris, Athanassios; Grossmann, Kenneth F; Sukari, Ammar; Wilson, Dawn; Zhang, Xiaosha; Sun, Jade; Glasser, Chad; Attie, Kenneth M; Sherman, Matthew L; Pandya, Susan S; Weiss, Jared.

Cancer ; 122(23): 3641-3649, 2016 Dec 01.

Article in English | MEDLINE | ID: mdl-27648727

6.

A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305.

Argiris, Athanassios; Flamand, Yael; Savvides, Panayiotis; Johnson, Jennifer M; Vathiotis, Ioannis; Levine, Marshall; Li, Shuli; Forastiere, Arlene A; Burtness, Barbara.

Eur J Cancer ; 199: 113509, 2024 Mar.

Article in English | MEDLINE | ID: mdl-38215573

7.

Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.

Serafini, Mara Serena; Cavalieri, Stefano; Licitra, Lisa; Pistore, Federico; Lenoci, Deborah; Canevari, Silvana; Airoldi, Mario; Cossu Rocca, Maria; Strojan, Primoz; Kuhar, Cvetka Grasic; Merlano, Marco; Perrone, Federica; Vingiani, Andrea; Denaro, Nerina; Perri, Francesco; Argiris, Athanassios; Gurizzan, Cristina; Ghi, Maria Grazia; Cassano, Alessandra; Allegrini, Giacomo; Bossi, Paolo; De Cecco, Loris.

J Immunother Cancer ; 12(1)2024 01 30.

Article in English | MEDLINE | ID: mdl-38290766

8.

Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck.

Johnson, Jennifer M; Vathiotis, Ioannis A; Harshyne, Larry A; Ali, Ayesha; Bar Ad, Voichita; Axelrod, Rita; Lorber, Emily; Curry, Joseph; Cognetti, David M; Luginbuhl, Adam J; Tuluc, Madalina; Keith, Scott; Mahoney, My G; Argiris, Athanassios.

J Immunother Cancer ; 11(8)2023 08.

Article in English | MEDLINE | ID: mdl-37536941

9.

CD8+ and FoxP3+ T-Cell Cellular Density and Spatial Distribution After Programmed Death-Ligand 1 Check Point Inhibition.

Curry, Joseph; Alnemri, Angela; Philips, Ramez; Fiorella, Michele; Sussman, Sarah; Stapp, Robert; Solomides, Charalambos; Harshyne, Larry; South, Andrew; Luginbuhl, Adam; Tuluc, Madalina; Martinez-Outschoorn, Ubaldo; Argiris, Athanassios; Linnenbach, Alban; Johnson, Jennifer.

Laryngoscope ; 133(8): 1875-1884, 2023 08.

Article in English | MEDLINE | ID: mdl-36125263

10.

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651.

Haddad, Robert I; Harrington, Kevin; Tahara, Makoto; Ferris, Robert L; Gillison, Maura; Fayette, Jerome; Daste, Amaury; Koralewski, Piotr; Zurawski, Bogdan; Taberna, Miren; Saba, Nabil F; Mak, Milena; Kawecki, Andrzej; Girotto, Gustavo; Alvarez Avitia, Miguel Angel; Even, Caroline; Toledo, Joaquin Gabriel Reinoso; Guminski, Alexander; Müller-Richter, Urs; Kiyota, Naomi; Roberts, Mustimbo; Khan, Tariq Aziz; Miller-Moslin, Karen; Wei, Li; Argiris, Athanassios.

J Clin Oncol ; 41(12): 2166-2180, 2023 04 20.

Article in English | MEDLINE | ID: mdl-36473143

11.

Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: a SEER cohort study.

Mehta, Rohtesh S; Lenzner, Diana; Argiris, Athanassios.

Ann Surg Oncol ; 19(3): 722-7, 2012 Mar.

Article in English | MEDLINE | ID: mdl-21947698

12.

Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies.

Argiris, Athanassios; Feinstein, Trevor M; Wang, Lin; Yang, Tianbing; Agrawal, Shruti; Appleman, Leonard J; Stoller, Ronald G; Grandis, Jennifer R; Egloff, Ann Marie.

Invest New Drugs ; 30(4): 1575-84, 2012 Aug.

Article in English | MEDLINE | ID: mdl-21881918

13.

Programmed cell death protein 1 axis blockade in locally advanced squamous cell carcinoma of the head and neck: Neoadjuvant and adjuvant approaches.

Vathiotis, Ioannis A; Johnson, Jennifer M; Luginbuhl, Adam; Cognetti, David; Curry, Joseph; Argiris, Athanassios.

Cancer Treat Rev ; 109: 102437, 2022 Sep.

Article in English | MEDLINE | ID: mdl-35868194

14.

Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era.

Saba, Nabil F; Vijayvargiya, Pooja; Vermorken, Jan B; Rodrigo, Juan P; Willems, Stefan M; Zidar, Nina; de Bree, Remco; Mäkitie, Antti; Wolf, Greg T; Argiris, Athanassios; Teng, Yong; Ferlito, Alfio.

Cancers (Basel) ; 14(5)2022 Feb 25.

Article in English | MEDLINE | ID: mdl-35267508

15.

Adjuvant Apatinib in Nasopharyngeal Carcinoma With Residual Epstein-Barr Virus DNA After Radiation Therapy: A Biomarker-Driven, Phase 2 Trial.

Liu, Xu; Guo, Ling; Xie, Fang-Yun; Hu, Wei-Han; Chen, Ming-Yuan; He, Qing-Mei; Xu, Zhi-Min; Zhang, Chu-Qing; Peng, Ying-Lin; Tang, Ling-Long; Mao, Yan-Ping; Sun, Rui; Li, Ji-Bin; Argiris, Athanassios; Hui, Edwin P; Sun, Ying; Ma, Jun.

Int J Radiat Oncol Biol Phys ; 113(5): 1063-1071, 2022 08 01.

Article in English | MEDLINE | ID: mdl-35550406

16.

Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma.

Luginbuhl, Adam J; Johnson, Jennifer M; Harshyne, Larry A; Linnenbach, Alban J; Shukla, Sanket K; Alnemri, Angela; Kumar, Gaurav; Cognetti, David M; Curry, Joseph M; Kotlov, Nikita; Antysheva, Zoya; Degryse, Sandrine; Mannion, Kyle; Gibson, Michael K; Netterville, James; Brown, Brandee; Axelrod, Rita; Zinner, Ralph; Tuluc, Madalina; Gargano, Stacey; Leiby, Benjamin E; Shimada, Ayako; Mahoney, My G; Martinez-Outschoorn, Ubaldo; Rodeck, Ulrich; Kim, Young J; South, Andrew P; Argiris, Athanassios.

Clin Cancer Res ; 28(5): 915-927, 2022 Mar 01.

Article in English | MEDLINE | ID: mdl-34911681

17.

A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).

Argiris, Athanassios; Ghebremichael, Musie; Burtness, Barbara; Axelrod, Rita S; Deconti, Ronald C; Forastiere, Arlene A.

Cancer ; 117(15): 3374-82, 2011 Aug 01.

Article in English | MEDLINE | ID: mdl-21246525

18.

EGFR inhibition for recurrent or metastatic HNSCC.

Argiris, Athanassios.

Lancet Oncol ; 16(5): 488-9, 2015 May.

Article in English | MEDLINE | ID: mdl-25892143

19.

Enhancing programmed cell death protein 1 axis inhibition in head and neck squamous cell carcinoma: Combination immunotherapy.

Vathiotis, Ioannis A; Johnson, Jennifer M; Argiris, Athanassios.

Cancer Treat Rev ; 97: 102192, 2021 Jun.

Article in English | MEDLINE | ID: mdl-33819755

20.

Preoperative Immunotherapy in the Multidisciplinary Management of Oral Cavity Cancer.

Philips, Ramez; Han, Chihun; Swendseid, Brian; Curry, Joseph; Argiris, Athanassios; Luginbuhl, Adam; Johnson, Jennifer.

Front Oncol ; 11: 682075, 2021.

Article in English | MEDLINE | ID: mdl-34277428

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: